Immediate Impact
50 standout
Citing Papers
Drug allergy: A 2022 practice parameter update
2022 Standout
Nanotechnology approaches for global infectious diseases
2021 Standout
Works of C Cohen being referenced
Rilpivirine Versus Efavirenz in HIV-1–Infected Subjects Receiving Emtricitabine/Tenofovir DF: Pooled 96-Week Data from ECHO and THRIVE Studies
2013
Primary prophylaxis for Pneumocystis carinii pneumonia in HIV-infected people with CD4 counts below 200/mm3: a cost-effectiveness analysis.
1991
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| C Cohen | 247 | 175 | 77 | 79 | 18 | 318 | |
| Joseph Drabo | 220 | 165 | 76 | 62 | 20 | 328 | |
| BG Gazzard | 193 | 108 | 80 | 62 | 20 | 343 | |
| Sorakij Bhakeecheep | 298 | 206 | 91 | 96 | 18 | 346 | |
| Lucas E. Hermans | 265 | 212 | 32 | 76 | 20 | 301 | |
| Raffaella Bucciardini | 258 | 170 | 97 | 86 | 26 | 310 | |
| Vincenzo Fragola | 264 | 182 | 98 | 85 | 32 | 313 | |
| Anitha J. Cecelia | 250 | 168 | 44 | 85 | 10 | 315 | |
| Roos E. Barth | 226 | 184 | 152 | 74 | 20 | 350 | |
| Suneeta Saghayam | 231 | 131 | 114 | 74 | 12 | 302 | |
| Jhon Rojas | 287 | 140 | 83 | 74 | 18 | 346 |
All Works
Loading papers...